298nok
0,0 %
Date:2025-04-28Time:16:24:00Latest report:Q4-2024List:Oslo GrowthTicker:EXTX
Market Cap:189 mnokEnterprise Value:90 mnokNet Sales:- mnokEarnings:−52,3 mnokEmployees:0ISIN:NO0010852213

Ratios

10-year key figure history for EXACT Therapeutics turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for EXACT Therapeutics with index and moving average MA50 and MA200.

Stockprice:2,98
MA50:3,32
MA200:4,78
Price/MA200:−37,7 %
RSI (14):39,6
Price/MA50:−10,2 %

Description

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing Acoustic Cluster Therapy (ACT), a promising non-invasive precision health technology for targeted enhancement of therapeutics. ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Medical Equipment